Sientra Appoints Vidur Sahney as Vice President, Operations and Supply Chain


Experienced Medical Device Manufacturing Executive to Lead Re-Supply Initiatives and Support New Product Pipeline Development and Innovation Activities

SANTA BARBARA, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, today announced that Vidur Sahney has been appointed Vice President, Operations and Supply Chain, effective immediately. Mr. Sahney adds over 11 years of implantable medical device operations, manufacturing, supply chain management and product development experience.

Jeffrey Nugent, Chairman and Chief Executive Officer of Sientra, said, “Vidur joins our management team at a very important juncture, as we advance toward finalizing a stable manufacturing supply solution for our breast implant products. We have completed final verification and testing of finished product in collaboration with our partner Vesta and remain on track to submit our PMA supplement to the FDA by the end of the first quarter of 2017. As we move toward that submission and anticipated approval, Vidur will be assuming responsibility for Sientra’s manufacturing and supply chain execution and I am confident that he will play a lead role in building a scalable operations function to contribute significantly to our short and long term growth objectives and product margin targets across our growing portfolio of surgical aesthetics products.”

Mr. Sahney most recently served as Senior Director of Operations at Thoratec, now part of St. Jude Medical, where he was responsible for commercializing the Company’s HeartMate PHP program. Previously, Mr. Sahney served as Senior Director of Manufacturing and Operations at CR Bard Vascular, formerly Loma Vista Medical, where he worked to take a novel class III fiber composite balloon catheter from conception to commercialization while managing key contract manufacturer relationships. Mr. Sahney also worked as a Manufacturing Engineering Manager at Abbott Vascular and as a Senior Manufacturing Process Engineer at Abbott Diabetes Care.  Mr. Sahney started his operations career at Toyota’s North American contract manufacturer, New United Motors Manufacturing, Inc. or NUMMI, where he learned the fundamentals of Lean Manufacturing.    

Mr. Sahney received a Bachelor of Science in Mechanical Engineering from San Francisco State University.

About Sientra  
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company committed to making a difference in patients’ lives by enhancing their body image, growing their self-esteem and restoring their confidence. The Company was founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The Company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants and breast tissue expanders exclusively to board-certified and board-admissible plastic surgeons and tailors its customer service offerings to their specific needs. The Company also offers a range of other aesthetic and specialty products including bioCorneum®, the professional choice in scar management.

Forward-looking statements  
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, based on management’s current assumptions and expectations of future events and trends, which affect or may affect the Company’s business, strategy, operations or financial performance, and actual results may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties.  Forward-looking statements include, but are not limited to, statements regarding expected growth and the Company’s intention to achieve a certain magnitude of growth in the future.  Such statements are subject to risks and uncertainties, including the Company’s inability to achieve and sustain growth at anticipated levels.  Additional factors that could cause actual results to differ materially from those contemplated in this press release can be found in the Risk Factors section of Sientra’s most recently filed Quarterly Report on Form 10-Q and and its Annual Report on Form 10-K for the year ended December 31, 2015 which Sientra filed with the Securities and Exchange Commission on March 10, 2016.  All statements other than statements of historical fact are forward-looking statements. The words ‘‘believe,’’ ‘‘may,’’ ‘‘might,’’ ‘‘could,’’ ‘‘will,’’ ‘‘aim,’’ ‘‘estimate,’’ ‘‘continue,’’ ‘‘anticipate,’’ ‘‘intend,’’ ‘‘expect,’’ ‘‘plan,’’ or the negative of those terms, and similar expressions that convey uncertainty of future events or outcomes are intended to identify forward-looking statements. Forward-looking statements speak only as of the date they were made, and, except to the extent required by law, the Company undertakes no obligation to update or review any forward-looking statement.

Investor Contacts:
The Ruth Group
Nick Laudico / Brian Johnston
(646) 536-7030 / (646) 536-7028

Primary Logo


Source: Sientra Inc.

Nasdaq: SIEN

Stock Quote: NASD

$0.84 -0.04
Volume 452,889
Previous Close 0.88
Intraday High 0.89
Intraday Low 0.81
Pricing delayed 20 minutes
Price Change % Change -4.95% 52 Week High 9.14 52 Week Low 0.80 Today's Open 0.89 Jun 29, 2022 04:00 PM

Investor Contact

Sientra Investor Relations